PSRC1 and metabolic syndrome: We noted higher methylation at this site lowers the level of PSRC1 (β = −0.24, p = 3.7e−192, Supplementary Table S3) and as the expression of this gene decreases the risk of dyslipidemia and CAD increases (Figure 6).